{"title":"Case Study: ICERs","markdown":{"yaml":{"title":"Case Study: ICERs","format":{"html":{"toc":false},"pdf":{"toc":false}}},"headingText":"Case 1 Description","containsRefs":false,"markdown":"\n\n::: callout-important\nPlease note that you can download PDF and Microsoft Word versions of this case study using the links on the right.\n:::\n\n\nYou seek to explore different drug strategies to treat HIV infection. Single agent therapy with retrocyclovir at 200mg per day has a mean discounted lifetime cost of \\$20,000 and results in a quality-adjusted life expectancy of 70 years. Single agent therapy with retrocyclovir at 400mg per day has a mean discounted lifetime cost of \\$22,000 and a quality adjusted life expectancy of 65 years (given the increased incidence of side effects with the higher dose). Another drug, centroflexavir (which comes only in one dose of 250 mg/day) has a mean total lifetime cost of \\$10,000 and a quality-adjusted life expectancy of 50 years. The combination of centroflexavir with low-dose retrocyclovir has a mean-life time cost of \\$40,000 and an average quality adjusted life expectancy of 80 years, while the combination of centroflexavir with high-dose retrocyclovir has a mean lifetime cost of \\$35,000 and a quality-adjusted life expectancy of 75 years.\n\nNewer ARTs are also available and their lifetime costs/QALYs are detailed below:\n\n|         | Cost   | QALY  |\n|---------|--------|-------|\n| ART 1/2 | 11,000 | 63.4  |\n| ART 1   | 15,525 | 73.52 |\n\n: Cost and QALY Outcomes for ARTs\n\n## Instructions\n\n*Perform a cost-effectiveness analysis of the treatment options using QALYs as the measure of health effects. Which strategy would you choose and why, if the willingness-to-pay threshold is \\$50,000 per quality-adjusted life year?*\n\n| Treatment          | Costs  | QALYs |\n|--------------------|--------|-------|\n| Do nothing         | 36,000 | 43.8  |\n| ART 1              | 15,525 | 73.52 |\n| ART 1/2            | 11,000 | 63.4  |\n| Retro 200          | 20,000 | 70.0  |\n| Retro 400          | 22,000 | 65.0  |\n| Centro             | 10,000 | 50.0  |\n| Centro / Retro 200 | 40,000 | 80.0  |\n| Centro / Retro 400 | 35,000 | 75.0  |\n\n<!-- ![](images/cs_icer_ans_1.1.png)    -->\n\n<!-- ![](images/cs_icer_ans_1.1.2.png)   -->\n\n<!-- ![](images/cs_icer_ans_1.1.3.png)    -->\n\n<!-- ![](images/cs_icer_ans_1.1.4.png)    -->\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: Treatment Options\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 1 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 2 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n\n# Case 2 Description\n\nYou are interested in performing a cost-effectiveness analysis of different cancer screening recommendations for anal squamous intraepithelial lesions and anal cancer in men.\n\nBelow is a table of the costs and quality-adjusted life years gained associated with different screening strategies over a six-year time span.\n\n## Instructions\n\n*Calculate incremental cost-effectiveness ratios for each strategy and determine which screening strategy you would choose if, as a decision maker, you were prepared to pay \\$50,000/QALY (using discounted quality-adjusted life years)*\n\n<!-- ![](images/cs_icer_ans_2.1.png) -->\n\n| Screening Strategy | Discounted QALYs | Discounted Costs (\\$2022) |\n|--------------------|------------------|---------------------------|\n| No screening       | 10.05            | 4,130                     |\n| Every 3 years      | 10.798           | 5,178                     |\n| Every 2 years      | 10.830           | 5,583                     |\n| Every 1 year       | 10.973           | 6,417                     |\n| Every 6 months     | 10.988           | 8,744                     |\n\n: Cost and QALY Outcomes, by Strategy\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 1 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 2 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n","srcMarkdownNoYaml":"\n\n::: callout-important\nPlease note that you can download PDF and Microsoft Word versions of this case study using the links on the right.\n:::\n\n# Case 1 Description\n\nYou seek to explore different drug strategies to treat HIV infection. Single agent therapy with retrocyclovir at 200mg per day has a mean discounted lifetime cost of \\$20,000 and results in a quality-adjusted life expectancy of 70 years. Single agent therapy with retrocyclovir at 400mg per day has a mean discounted lifetime cost of \\$22,000 and a quality adjusted life expectancy of 65 years (given the increased incidence of side effects with the higher dose). Another drug, centroflexavir (which comes only in one dose of 250 mg/day) has a mean total lifetime cost of \\$10,000 and a quality-adjusted life expectancy of 50 years. The combination of centroflexavir with low-dose retrocyclovir has a mean-life time cost of \\$40,000 and an average quality adjusted life expectancy of 80 years, while the combination of centroflexavir with high-dose retrocyclovir has a mean lifetime cost of \\$35,000 and a quality-adjusted life expectancy of 75 years.\n\nNewer ARTs are also available and their lifetime costs/QALYs are detailed below:\n\n|         | Cost   | QALY  |\n|---------|--------|-------|\n| ART 1/2 | 11,000 | 63.4  |\n| ART 1   | 15,525 | 73.52 |\n\n: Cost and QALY Outcomes for ARTs\n\n## Instructions\n\n*Perform a cost-effectiveness analysis of the treatment options using QALYs as the measure of health effects. Which strategy would you choose and why, if the willingness-to-pay threshold is \\$50,000 per quality-adjusted life year?*\n\n| Treatment          | Costs  | QALYs |\n|--------------------|--------|-------|\n| Do nothing         | 36,000 | 43.8  |\n| ART 1              | 15,525 | 73.52 |\n| ART 1/2            | 11,000 | 63.4  |\n| Retro 200          | 20,000 | 70.0  |\n| Retro 400          | 22,000 | 65.0  |\n| Centro             | 10,000 | 50.0  |\n| Centro / Retro 200 | 40,000 | 80.0  |\n| Centro / Retro 400 | 35,000 | 75.0  |\n\n<!-- ![](images/cs_icer_ans_1.1.png)    -->\n\n<!-- ![](images/cs_icer_ans_1.1.2.png)   -->\n\n<!-- ![](images/cs_icer_ans_1.1.3.png)    -->\n\n<!-- ![](images/cs_icer_ans_1.1.4.png)    -->\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: Treatment Options\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 1 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 2 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n\n# Case 2 Description\n\nYou are interested in performing a cost-effectiveness analysis of different cancer screening recommendations for anal squamous intraepithelial lesions and anal cancer in men.\n\nBelow is a table of the costs and quality-adjusted life years gained associated with different screening strategies over a six-year time span.\n\n## Instructions\n\n*Calculate incremental cost-effectiveness ratios for each strategy and determine which screening strategy you would choose if, as a decision maker, you were prepared to pay \\$50,000/QALY (using discounted quality-adjusted life years)*\n\n<!-- ![](images/cs_icer_ans_2.1.png) -->\n\n| Screening Strategy | Discounted QALYs | Discounted Costs (\\$2022) |\n|--------------------|------------------|---------------------------|\n| No screening       | 10.05            | 4,130                     |\n| Every 3 years      | 10.798           | 5,178                     |\n| Every 2 years      | 10.830           | 5,583                     |\n| Every 1 year       | 10.973           | 6,417                     |\n| Every 6 months     | 10.988           | 8,744                     |\n\n: Cost and QALY Outcomes, by Strategy\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 1 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n\n| Strategy | Discounted Costs | Discounted QALYs | Incremental Costs | Incremental QALYs | ICER (\\$/QALY) |\n|------------|------------|------------|------------|------------|------------|\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n|          |                  |                  |                   |                   |                |\n\n: ICER Calculation Table 2 {tbl-colwidths=\"\\[20,20,20,20,20,20\\]\"}\n"},"formats":{"html":{"identifier":{"display-name":"HTML","target-format":"html","base-format":"html"},"execute":{"fig-width":7,"fig-height":5,"fig-format":"retina","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":true,"output":true,"warning":true,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"markdown"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":false,"prefer-html":false,"output-divs":true,"output-ext":"html","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":"auto","merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[],"notebook-links":true},"pandoc":{"standalone":true,"wrap":"none","default-image-extension":"png","to":"html","css":["../styles.css"],"toc":false,"output-file":"cs_icer.html"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","appendix-view-license":"View License","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words","listing-page-filter":"Filter","draft":"Draft"},"metadata":{"lang":"en","fig-responsive":true,"quarto-version":"1.8.24","theme":"cosmo","title":"Case Study: ICERs"},"extensions":{"book":{"multiFile":true}}},"pdf":{"identifier":{"display-name":"PDF","target-format":"pdf","base-format":"pdf"},"execute":{"fig-width":5.5,"fig-height":3.5,"fig-format":"pdf","fig-dpi":300,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":true,"output":true,"warning":true,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"markdown"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":false,"prefer-html":false,"output-divs":true,"output-ext":"pdf","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":true,"merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[]},"pandoc":{"pdf-engine":"lualatex","standalone":true,"variables":{"graphics":true,"tables":true},"default-image-extension":"pdf","to":"pdf","toc":false,"output-file":"cs_icer.pdf"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","appendix-view-license":"View License","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words","listing-page-filter":"Filter","draft":"Draft"},"metadata":{"block-headings":true,"title":"Case Study: ICERs"},"extensions":{"book":{"selfContainedOutput":true}}}},"projectFormats":["html"]}